ArticleThe journal of headache and pain2021

Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment - real world outcomes.

J Talbot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.